FDA.reportPublic FDA data

ARNUITY ELLIPTA 100 MCG/INHAL Dry Powder Inhaler, 14 Blisters

RxCUI
1547664
RxNorm name
ARNUITY ELLIPTA 100 MCG/INHAL Dry Powder Inhaler, 14 Blisters
Display name
ARNUITY ELLIPTA 100 MCG/INHAL Dry Powder Inhaler, 14 Blisters
Full name
ARNUITY ELLIPTA 100 MCG/INHAL Dry Powder Inhaler, 14 Blisters
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:58

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
50f193ee-1691-486d-9370-a664df63695cARNUITY ELLIPTA 100 MCG/INHAL Dry Powder Inhaler, 14 BlistersPSN17These highlights do not include all the information needed to use ARNUITY ELLIPTA safely and effectively. See full prescribing information for ARNUITY ELLIPTA. ARNUITY ELLIPTA (fluticasone furoate inhalation powder), for oral inhalation use Initial U.S. Approval: 201420231018
50f193ee-1691-486d-9370-a664df63695cArnuity Ellipta 100 MCG/ACTUAT Dry Powder Inhaler, 14 ACTUATSY17These highlights do not include all the information needed to use ARNUITY ELLIPTA safely and effectively. See full prescribing information for ARNUITY ELLIPTA. ARNUITY ELLIPTA (fluticasone furoate inhalation powder), for oral inhalation use Initial U.S. Approval: 201420231018
50f193ee-1691-486d-9370-a664df63695c14 ACTUAT fluticasone furoate 0.1 MG/ACTUAT Dry Powder Inhaler [Arnuity]SBD17These highlights do not include all the information needed to use ARNUITY ELLIPTA safely and effectively. See full prescribing information for ARNUITY ELLIPTA. ARNUITY ELLIPTA (fluticasone furoate inhalation powder), for oral inhalation use Initial U.S. Approval: 201420231018
50f193ee-1691-486d-9370-a664df63695cArnuity 0.1 MG/ACTUAT Dry Powder Inhaler, 14 ACTUATSY17These highlights do not include all the information needed to use ARNUITY ELLIPTA safely and effectively. See full prescribing information for ARNUITY ELLIPTA. ARNUITY ELLIPTA (fluticasone furoate inhalation powder), for oral inhalation use Initial U.S. Approval: 201420231018